TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 520.43B
Enterprise Value 351.91B
Trailing P/E N/A
Forward P/E 17.07
PEG Ratio (5 yr expected) 1-1.51
Price/Sales (ttm)0.91
Price/Book (mrq)1.49
Enterprise Value/Revenue 32.32
Enterprise Value/EBITDA 68.52

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin -72.66%
Operating Margin (ttm)17.77%

Management Effectiveness

Return on Assets (ttm)3.04%
Return on Equity (ttm)-61.22%

Income Statement

Revenue (ttm)22.39B
Revenue Per Share (ttm)22.03
Quarterly Revenue Growth (yoy)-15.90%
Gross Profit (ttm)10.82B
EBITDA 6.09B
Net Income Avi to Common (ttm)-16.52B
Diluted EPS (ttm)-16.26
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)977M
Total Cash Per Share (mrq)0.96
Total Debt (mrq)32.48B
Total Debt/Equity (mrq)173.25
Current Ratio (mrq)0.86
Book Value Per Share (mrq)13.50

Cash Flow Statement

Operating Cash Flow (ttm)3.51B
Levered Free Cash Flow (ttm)3.53B

Trading Information

Stock Price History

Beta 0.81
52-Week Change 3-44.22%
S&P500 52-Week Change 314.91%
52 Week High 336.20
52 Week Low 310.85
50-Day Moving Average 320.33
200-Day Moving Average 316.96

Share Statistics

Avg Vol (3 month) 323.09M
Avg Vol (10 day) 321.32M
Shares Outstanding 51.02B
Float 950.71M
% Held by Insiders 13.58%
% Held by Institutions 162.61%
Shares Short 392.8M
Short Ratio 33.33
Short % of Float 30.00%
Shares Short (prior month) 367.93M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 40.00%
Trailing Annual Dividend Rate 30.51
Trailing Annual Dividend Yield 32.55%
5 Year Average Dividend Yield 43.16
Payout Ratio 40.00%
Dividend Date 3Dec 12, 2017
Ex-Dividend Date 4Nov 27, 2017
Last Split Factor (new per old) 22/1
Last Split Date 3Jul 1, 2004